News Snapshot:
China National Biotec Group (CNBG) and Sinovac Biotech Ltd said on Saturday, September 5 that four more countries have come to an agreement to run phase three clinical trials of Chinese COVID-19 vaccine candidates. As reported Serbia and Pakistan are among the new countries ready to late-stage trials, as CNBG and Sinovac seek more data overseas amid diminishing cases of Coronavirus in China. Coronavirus vaccine (Representational Image) Twitter Trials Abroad Serbia will test two COVID-19 vaccines developed by CNBG's Wuhan and Beijing units, while Pakistan has agreed to test the Beijing unit's vaccine candidate. As per CNBG vice president Zhang...
